[1]
Salunke, S. et al. 2022. A Randomized, Open-Label, Two-way Crossover Bioequivalence Study of Cilacar Tablet Compared with Atelec Tablet in Healthy Volunteers Under Fasting Condition. Journal of Drug Delivery and Therapeutics. 12, 2 (Mar. 2022), 37–42. DOI:https://doi.org/10.22270/jddt.v12i2.5233.